Stocks and Investing
Stocks and Investing
Tue, March 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (VIGL) at Hold with Increased Target to $13 on, Mar 27th, 2023
Matthew Harrison of Morgan Stanley, Maintained "Vigil Neuroscience, Inc." (VIGL) at Hold with Increased Target from $12 to $13 on, Mar 27th, 2023.
Matthew has made no other calls on VIGL in the last 4 months.
There is 1 other peer that has a rating on VIGL. Out of the 1 peers that are also analyzing VIGL, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $24 on, Wednesday, March 22nd, 2023
Contributing Sources